Introduction
Stroke is the second leading cause of death and the most common cause of disability throughout the world. 1 Much research has gone into the elucidation of the etiological and pathological mechanisms of this multifactorial disease. In addition to the conventional risk factors, clinical and epidemiological studies have repeatedly supported the role of thrombus formation in common stroke susceptibility. 2 The coagulation system is governed by a subtle balance between clotting activators and inhibitors. However, several inherited or acquired factors may cause the shift of this balance toward thrombosis. In The aim of this study was to evaluate the prevalence of factor V Leiden (FVL), prothrombin G20210A, methylenetetrahydrofolate reductase (MTHFR) C677T gene mutations, and angiotensin-converting enzyme (ACE) I/D polymorphism in ischemic stroke (IS) patients. A total of 162 Turkish IS patients were included and analyzed according to stroke subtype by the TOAST classification. Their genotype data were compared with those of the control group, representing the healthy population, using the χ 2 test. The frequency of FVL heterozygocity was 12.3% in this series-higher than that in the normal population (9.8%; statistically insignificant, P = .478). The frequency of the ACE D/D genotype in all stroke patients and those with stroke of undetermined etiology was higher than that in our population (52.5% and 59.2%, respectively, vs 39.3%; statistically significant, P = .034, P = .020). Our results may suggest that ACE D/D genotype is a risk factor for IS, particularly in those with stroke of undetermined etiology in the Turkish population.
which predisposes to hyperhomocysteinemia. The increase in the blood homocysteine level may cause vascular endothelial damage that facilitates thrombus formation. 5 Angiotensin-converting enzyme (ACE) acts predominantly as an ectoenzyme of vascular endothelial cells and is a component of the renin-angiotensin and kallikrein-kinin systems. So ACE may participate in vascular homeostasis. The insertion/deletion (I/D) polymorphism of this gene is known to be associated with variation of plasma and cellular ACE concentrations. Furthermore, the DD genotype has been associated with a change in arterial function. Metaanalysis confirmed the association of the D allele with arterial atherothrombotic diseases in whites. 6, 7 In view of the fact that the prevalence of molecular risk factors for thrombosis varies greatly in different parts of the world, both in patients with thrombosis and in the general population, we felt that it was prudent to evaluate further the relation between the 3 common mutations (FV G1691A, PtG20210A, MTHFRC677T) and ACE I/D polymorphism as risk factors for ischemic stroke (IS) and stroke subtypes in the Turkish population.
Patients and Methods
The study involved 162 patients (75 female, 87 male) who were admitted to the Neurology Department of Baskent University Hospital in Ankara, Turkey, with acute IS, between 2000 and 2003. The mean age of the patients was 69.2 years. All participants underwent a detailed clinical examination, evaluation for vascular risk factors, general and neurological examinations, extended laboratory studies, electrocardiography, transthoracic and/or transesophageal echocardiography, carotid Doppler ultrasonography, and magnetic resonance imaging (MRI), including diffusion weighted MRI and MR angiography. Patients were divided into 4 subgroups as follows: large artery atherosclerosis (n = 15, 10%), cardioembolism (n = 78, 48%), small-vessel occlusion (n = 20, 12%), and undetermined etiology (n = 49, 30%) according to the classification in the Trial of Org 10172 in Acute Stroke Treatment (TOAST). 8
Genotyping
All patients gave informed consent for DNA analysis. The ethics committee of Baskent University approved the study protocol. Genomic DNA was prepared from leukocyte pellets by sodium dodecyl sulfate lysis, ammonium acetate extraction, and ethanol precipitation. 9 The primers used and the conditions for polymerase chain reaction (PCR) analysis were as described previously. [10] [11] [12] FV G1691A mutation was determined after digestion with Hind III, which yielded 241-bp bands in the presence of the G allele and 209-and 32-bp bands in the presence of the A allele. 10 To analyze for the Pt G20210A mutation, the 345-bp PCR product was digested with Hind III. Because the 20210G allele lacks a Hind III site, electrophoresis of such samples revealed the 345-bp fragment only; however, the 20210A variant was cut into 2 bands of 322 and 23 bp. 10 A 198-bp PCR product was digested with Hinf I for MTHFR C677T mutation. Detection of uncut product (198-bp) indicated the presence of the C allele, whereas detection of 175-and 23-bp products indicated the T allele. 11 I/D polymorphism of ACE was also detected by electrophoretic separation of PCR products. The presence of a 190-bp product indicated the I allele, whereas presence of a 490-bp product indicated the D allele. Each DNA sample revealed 1 of the 3 possible patterns after electrophoresis: a 190-bp band (genotype DD), a 490-bp band (genotype II), or both bands (genotype ID). 12 The results were compared with findings previously published for the healthy Turkish population. [13] [14] [15] [16] The patients in these groups met the inclusion criteria as being randomly selected, unrelated, apparently healthy individuals without family history of or any evidence for present thrombosis; they were either blood bank donors or patients visiting our hospital for mild illnesses.
The Statistical Package for Social Science (SPSS Inc version 11.0 for Windows) was used for statistical analyses. Differences between patients and the population were analyzed using the chi-square test and accepted as statistically significant for P < .05.
Results
The 162 patients with acute IS comprised 75 women and 87 men, with the mean age being 69.8 years (age range, 24-94 years). Among them, 106 patients had hypertension, 43 had diabetes mellitus, 43 had coronary artery disease, and 63 had hyperlipidemia.
In addition, 3 patients had malignancy, 2 had systemic lupus erythematosis, and 1 had polycythemia vera.
When the patients were classified according to TOAST, there were 15 patients in group I representing large artery atherosclerosis, 78 in group II representing cardioembolic disorders, 20 in group III representing small-vessel occlusion, and 49 in group IV representing stroke of undetermined etiology. For 34 patients in group IV it was not possible to determine any etiological factor for stroke; however, 15 patients with tandem pathologies were included in this group.
The heterozygocity rate for the FV G1691A mutation in all patients was 12.3% (n = 20); 1 patient was homozygous. The heterozygocity of the FV G1691A mutation in the Turkish population was reported as 9.8% previously. 13 Although the frequency of the FV G1691A mutation was higher than in the normal population, this was statistically insignificant. When we analyzed the FV G1691A mutation frequency according to stroke subtypes, it was 14.1% in the cardioembolic group and 16.3% in the undetermined etiology group (Table 1) . Although the FV G1691A mutation frequencies in these groups were both higher than that in the normal population, this was not statistically significant either.
Heterozygous Pt gene mutation was determined only in 3 (1.9%) patients. There was no statistically significant difference when we compared the value for all patients and patient subtypes with the normal population values ( Table 2) .
MTHFR C677T heterozygocity was determined in only 4 patients (2.5%); there was no homozygote mutant patient. In our population, 37 heterozygous (34.9%) and 6 homozygous (5.6%) individuals were reported among 107 people. 15 The frequency of the MTHFR C677T mutation in our patient group was lower than that in the normal population.
The distribution of ACE genotypes in our patients with stroke was as follows: 19 patients (11.7%) were I/I, 58 (35.8%) were I/D, and 85 (52.5%) were D/D (Table 3 ). Akar et al 16 In all groups, the I/D genotype in patients with IS was lower than that in the normal Turkish population (35.8%): large artery atherosclerosis, 5 patients (33.3%); cardioembolic, 30 patients (38.5%); small-vessel occlusion, 8 patients (40%; P = .745, statistically insignificant); undetermined etiology, 15 patients (30.6%). Altogether, 85 patients had the D/D genotype; this was significantly higher than in the normal Turkish population (P = .034). There was no statistically significant difference when we compared subgroups according to the D/D genotype with the normal Turkish population. For the undetermined etiology group, the number of patients having the D/D genotype was 29 (59.2%); this was significantly higher than that in the normal Turkish population (39.3%; P = .020). Although it was not the focus of our study, because our patient population included 106 hypertensive patients, we compared I/D and D/D allele frequencies between normotensive and hypertensive patients and found that they were not statistically significant (for I/D P = .309 and for D/D P = .263).
Discussion
Although previous studies on different ethnic groups established that FV G1691A Pt G20210A, and MTHFR C677T mutations were not risk factors for IS alone, it has been shown that more than 1 gene mutation or a mutation together with traditional stroke risk factors increases the incidence of IS. Therefore, this study was conducted to determine the molecular risk factor for IS and to clarify the possible role of these mutations in Turkish stroke subtypes.
Although cardioembolism represents approximately 25% of IS in previous reports, in our study, it was the largest group (78 patients, 48.1%). 17 As all patients were evaluated with diffusion MRI in our study, it was easier to see small lesions in the distribution of other arteries different from the symptomatic lesion. When a patient had multiple lesions in the distribution of more than 1 artery, it was considered to be embolic in origin. This may explain the discrepancy between our findings and previous reports. We propose that the distinction between the subgroups of IS are not distinct enough and that there are some overlaps. This classification seems to achieve precision and clarity when advanced imaging and laboratory techniques are used. A number of studies have reported an association between ACE gene I/D polymorphism and stroke. A meta-analysis that evaluated the risk of stroke in 1918 participants versus 722 controls in 7 studies showed that the D allele is a modest but independent risk factor for the onset of IS. 18 A positive association between ACE polymorphism, especially the D/D genotype and IS, has been found in most of those studies. [19] [20] [21] [22] [23] [24] Furthermore, many studies showed an association between the DD genotype of the ACE gene and small-vessel occlusion or large artery atherosclerosis. However, Markus and colleagues, 19 by using the TOAST classification in 100 patients with ischemia in the carotid arterial territory, showed that there was no relationship between ACE polymorphism and carotid atherosclerosis. However, they found a high frequency of polymorphism in the IS and small-vessel occlusion group. Hence, a clearly higher frequency of the D/D genotype of the ACE gene in patients with carotid atherosclerosis was reported. 23, 24 In our study, the ACE I/D genotype frequency (35.8%) was not more than that in the general population, whereas the D/D genotype frequency was significantly higher (52.5%; P = .181). The higher frequency of the ACE D/D genotype in the cardioembolic group compared with the normal population was statistically insignificant (P = .199). The frequency of the D/D genotype in the undetermined etiology group (59.2%) was also significantly higher than that in the normal population (P = .020). In our study, the higher frequency of D/D genotype in group IV can be explained by the existence of patients with 2 or more potential causes.
According to the TOAST classification, there were 11 patients with large artery atherosclerosis and 2 with small-vessel occlusion in the undetermined etiology group. When those 11 patients were classified in group I, the results changed as follows: the number of patients with large artery atherosclerosis increased from 15 to 26; I/I was found in 2 (7.7%), I/D in 7 (26.9%), and D/D in 17 (65.4%). As the frequency of the I/D genotype decreased, that of the D/D genotype significantly increased (P = .016). Our study seems to support others showing a relationship between carotid atherosclerosis and the D allele. When the 2 patients mentioned above were included in group III, the slight increase in frequencies of both the I/D and D/D genotypes was statistically insignificant (I/D, P = .795; D/D, P = .589). Although other studies have shown a correlation between small-vessel occlusion and ACE D/D genotype, the present results do not seem to support this association, possibly because of the small number of patients (20/162) in group III. The frequency of FV G1691A mutations in different populations is reported to be 2% to 14%, depending on ethnic background and geographical location. 25 In our population, it has been reported to be 9.8%. 13 Heterozygocity of the FV G1691A mutation has been reported to increase the risk of venous thromboembolism 7-to 10-fold, and homozygote mutants increase it 100-fold. 26 A few studies have found an association between FV G1691A and IS, but these studies involved only a few patients or families. 27, 28 In contrast, other studies have found no association between these 2 parameters, as did our study. [29] [30] [31] [32] [33] [34] [35] According to the results of our study, FV G1691A mutation was not associated with IS or its subtypes in our study population.
The worldwide frequency of the Pt gene G20210A mutation is reported to be 0.7% to 4%. 36 Heterozygocity of this mutation has been associated with a 3-fold increase in the risk of venous thromboembolism. 37 A few studies have shown that this mutation increases the risk of arterial thrombosis. In one study, 72 patients under the age of 50 years were examined for FV G1691A, Pt G20210A, and MTHFR C677T mutations. Although there was no relationship with FV G1691A and MTHFR C677T, there was an increase in Pt G20210A mutation frequency in these patients, and the authors claimed that Pt G20210A heterozygocity increases the risk of cerebral ischemia by 3 to 8 times. 38 The frequency of Pt G20210A in the Turkish population has been reported to be 2.7%, whereas in our patients it was 1.9%. 14 Most other studies of the Pt G20210A gene mutation support our findings in which no association was found between the relevant mutation and IS. 34, 39 An elevated plasma level of homocysteine is considered to be an independent risk factor for atherosclerosis. 40 A common thermolabile variant of the enzyme MTHFR has been shown to be associated with elevated levels of homocysteine. 41 It was therefore speculated that this mutation represents a common genetic risk factor for arterial vascular disease. There are several studies showing no relationship between this mutation and IS. 35, 42 Frequency of the MTHFR C677T mutation has been reported to be 34.9% for our population. 15 We found heterozygocity only in 4 patients. According to our results, the MTHFR C677T mutation is not associated with IS and its subtypes in Turkish patients.
In conclusion, our results suggest that frequencies of FV G1691A, Pt G20120A, and MTHFR C677T mutations are not higher in IS patients than those in our healthy population. So these mutations cannot be considered as risk factors for IS and its subtypes. However, the frequency of the ACE D/D genotype is higher in IS patients and the undetermined etiology group compared with that in our population, suggesting that this genotype is a risk factor in these patients. Further evaluation in a larger series is required to determine whether these gene mutations are risk factors for large artery atherosclerosis and small-vessel occlusion in Turkish patients.
